Becoming a "Treatment Success": What Helps and What Hinders Patients from Achieving and Sustaining Undetectable Viral Loads
- 1 May 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 20 (5) , 326-334
- https://doi.org/10.1089/apc.2006.20.326
Abstract
Highly active antiretroviral therapy (HAART) adherence research has focused predominantly on individuals with less than optimal clinical outcomes; therefore, little is known about the experiences of individuals who sustain undetectable viral loads. The present study used a qualitative method to explore how individuals who have sustained undetectable viral loads account for their success, and to identify challenges, as well as possible needs, for continued success. Participants were 20 patients at an outpatient infectious disease clinic in an urban center. Participants completed two 60-minute interviews. The Critical Incident Technique was used to identify and classify critical incidents linked with sustaining treatment success. Of the 438 critical incidents collected, 316 were identified as helpful and 122 were identified as unhelpful. Helpful categories included resolving ambivalence, using personal strengths, and fostering helpful relationships. Unhelpful categories were mood, lack of social support, financial difficulties, and medication factors. Doing well on antiretroviral therapy is a dynamic process that requires ongoing attention from both the patient and care provider. The results of this study highlight the efforts of patients to maintain their health and remind care providers not to assume that patients are not facing continuous challenges. Findings from the present study suggest that psychosocial factors do contribute to improved clinical outcomes in patients taking HAART.Keywords
This publication has 18 references indexed in Scilit:
- The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/LAnnals of Internal Medicine, 2003
- Polymorphism in Protease and Reverse Transcriptase and Phenotypic Drug Resistance of HIV-1 Recombinant CRF02_AG Isolates From Patients With No Prior Use of Antiretroviral Drugs in Abidjan, Côte d'IvoireJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Adherence to HAART RegimensAIDS Patient Care and STDs, 2003
- Adherence to Medication Treatment: A Qualitative Study of Facilitators and Barriers Among a Diverse Sample of HIV+ Men and Women in Four U.S. CitiesAIDS and Behavior, 2003
- Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Patient adherence to HIV medication regimens: a review of published and abstract reportsPatient Education and Counseling, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Barriers to Adherence to Highly Active Antiretroviral Therapy As Expressed by People Living with HIV/AIDSAIDS Patient Care and STDs, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998